In short: "Sang Sam biologics in Korea" — the Korean acquirer that bid on Monday for his Swiss holding PolyPeptide. Named only as an international acquirer, evidence that the bids are increasingly coming from outside the US.
11:11Last week we had Rotorque from the UK get a takeover offer from Big Bad AB from Switzerland. And then on Monday this week we had a company from Switzerland that we owned in the healthcare biologic space called Polyeptide. they got a takeover offer from Sang Sam biologics in Korea. So we're our underwriting thesis our process is being validated where by which we are seeing more and more takeovers and they're happening outside of the US.
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.